• Mashup Score: 1

    This cohort study examines receipt of telehealth services, medications for opioid use disorder (MOUD: methadone, buprenorphine, and extended-release naltrexone) receipt and retention, and medically treated overdose before and during the COVID-19 pandemic among Medicare beneficiaries.

    Tweet Tweets with this article
    • Emergency authorities to expand telehealth and provide flexibilities for medications for opioid use disorder during #COVID19 were used among Medicare beneficiaries & were associated with improved retention and lower odds for nonfatal overdose. https://t.co/QqFw9Ccbxf #PsyResearch

  • Mashup Score: 6

    This cohort study examines receipt of telehealth services, medications for opioid use disorder (MOUD: methadone, buprenorphine, and extended-release naltrexone) receipt and retention, and medically treated overdose before and during the COVID-19 pandemic among Medicare beneficiaries.

    Tweet Tweets with this article
    • Emergency authorities to expand telehealth and provide flexibilities for medications for opioid use disorder during #COVID19 were used among Medicare beneficiaries & were associated with improved retention and lower odds for nonfatal overdose. https://t.co/4hyUeXEmVd #PsyResearch

  • Mashup Score: 3

    This cohort study examines receipt of telehealth services, medications for opioid use disorder (MOUD: methadone, buprenorphine, and extended-release naltrexone) receipt and retention, and medically treated overdose before and during the COVID-19 pandemic among Medicare beneficiaries.

    Tweet Tweets with this article
    • Emergency authorities to expand telehealth and provide flexibilities for medications for opioid use disorder during #COVID19 were used among Medicare beneficiaries & were associated with improved retention and lower odds for nonfatal overdose. https://t.co/q5yE2Z1dA1 #PsyResearch

  • Mashup Score: 1

    This cohort study examines receipt of telehealth services, medications for opioid use disorder (MOUD: methadone, buprenorphine, and extended-release naltrexone) receipt and retention, and medically treated overdose before and during the COVID-19 pandemic among Medicare beneficiaries.

    Tweet Tweets with this article
    • Emergency authorities to expand telehealth and provide flexibilities for medications for opioid use disorder during #COVID19 were used among Medicare beneficiaries & were associated with improved retention and lower odds for nonfatal overdose. https://t.co/OKyTo13KSo #PsyResearch